Retatrutide is a triple agonist (GLP-1, GIP, and glucagon receptors) currently in clinical trials
Week-by-week tracking template For each injection, record the following: Date and time of injection Dose in mg (prescribed amount) Concentration of vial (mg/ml) Units drawn on syringe Injection site (rotate between abdomen, thigh, upper arm) Side effects (none, mild, moderate, severe) Weight (weekly, same scale, same conditions) Notes (food tolerance, energy levels, appetite changes) This data becomes invaluable when making titration decisions with your provider
Carolyn Bramante is an associate professor at the University of Minnesota Medical School who specializes in obesity and weight loss
Understanding the realistic timeline of glutathione treatment is essential for setting proper expectations